News
Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System
-
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM; “Adagio Medical”, “Adagio” or the “Company”), a leading innovator in catheter ablation technologies, today announced the completion of the first procedures in FULCRUM-VT U.S. Food and Drug Administration (FDA) Pivotal IDE study of Adagio's VT Cryoablation System. Procedures were performed by Professor William G. Stevenson, MD, at Vanderbilt University Medical Center in Nashville, TN and Dr. J. David Burkhardt at.10/24/2024
Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias
-
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM; the “Company”), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced its sponsorship and participation in the 19th Annual International Symposium on Ventricular Arrhythmias, to be held at the New York Marriott at the Brooklyn Bridge on October 11-12, 2024. In addition to participating in the commercial exhibition, Adagio's proprietary Ultra-Low Temperature C.10/07/2024
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions
Is Adagio Medical Holdings, Inc. (ADGM) a buy, sell, or hold?
Adagio Medical Holdings, Inc. (ADGM) can sell. Click on Rating Page for detail.
What is Adagio Medical Holdings, Inc.'s stock price?
The price of Adagio Medical Holdings, Inc. (ADGM) is 1.17 and it was updated on 2025-02-04 13:00:45.
Is Adagio Medical Holdings, Inc. (ADGM) overvalued or undervalued?
Currently Adagio Medical Holdings, Inc. (ADGM) is in undervalued.
SEC Filings
Press Releases
| StockPrice Release |
|---|
ADGM Ratings Summary
ADGM Quant Ranking
